Get the Stockscreener App
16.20
1.57%
0.25
After Hours:
16.20
Evolus Inc stock is traded at $16.20, with a volume of 492.90K.
It is up +1.57% in the last 24 hours and up +1.95% over the past month.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
See More
Previous Close:
$15.95
Open:
$15.75
24h Volume:
492.90K
Relative Volume:
0.95
Market Cap:
$1.02B
Revenue:
$202.09M
Net Income/Loss:
$-61.69M
P/E Ratio:
-13.85
EPS:
-1.17
Net Cash Flow:
$-35.64M
1W Performance:
+4.31%
1M Performance:
+1.95%
6M Performance:
+15.71%
1Y Performance:
+77.24%
1-Day Range:
$15.75
$16.37
1-Week Range:
$15.31
$16.73
52-Week Range:
$7.44
$17.70
Evolus Inc Stock (EOLS) Company Profile
Name
Evolus Inc
Sector
Phone
(949) 284-4555
Address
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Evolus Inc Stock (EOLS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-23-22 | Initiated | Needham | Buy |
| May-12-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-20-22 | Upgrade | Truist | Hold → Buy |
| May-06-21 | Upgrade | Mizuho | Neutral → Buy |
| Apr-08-21 | Reiterated | H.C. Wainwright | Buy |
| Feb-24-21 | Downgrade | Truist | Buy → Hold |
| Jul-07-20 | Downgrade | Mizuho | Buy → Neutral |
| Feb-06-20 | Resumed | Mizuho | Buy |
| Nov-26-19 | Initiated | SVB Leerink | Outperform |
| Sep-05-19 | Resumed | Mizuho | Buy |
| Jun-28-19 | Initiated | Wells Fargo | Market Perform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Feb-14-19 | Initiated | H.C. Wainwright | Buy |
| Jan-29-19 | Initiated | Stifel | Buy |
View All
Evolus Inc Stock (EOLS) Latest News
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Midday Stock Roundup: STAAR Surgical CO. Shares Surge 22% - Orange County Business Journal
Armistice Capital LLC Takes Position in Evolus, Inc. (NASDAQ:EOLS) - MarketBeat
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Evolus Defeats Investor Suit Over Botox Trade Secret Dispute - Bloomberg Law
Great Point Partners LLC Has $26.60 Million Stock Holdings in Evolus, Inc. (NASDAQ:EOLS) - Defense World
Evolus Inc (EOLS) Shares Up 3.22% on Sep 20 - GuruFocus.com
Evolus Elite Summit – Paris, France: Aesthetic Lab's Bold Journey to Innovation and Excellence - EIN News
Quest Partners LLC Purchases Shares of 3,964 Evolus, Inc. (NASDAQ:EOLS) - Defense World
When (EOLS) Moves Investors should Listen - Stock Traders Daily
Evolus Unveils New Branding for Flagship Product Jeuveau® to Ref - GuruFocus.com
Evolus Bus Event - StyleBlueprint
Bank of New York Mellon Corp Acquires 35,760 Shares of Evolus, Inc. (NASDAQ:EOLS) - MarketBeat
Evolus (NASDAQ:EOLS) Stock Rating Reaffirmed by Cantor Fitzgerald - MarketBeat
Evolus Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Evolus Rings the Closing Bell - Nasdaq
Los Angeles Capital Management LLC Sells 45,216 Shares of Evolus, Inc. (NASDAQ:EOLS) - MarketBeat
Evolus Insiders Sold US$5.6m Of Shares Suggesting Hesitancy - Simply Wall St
Barclays Raises Evolus (NASDAQ:EOLS) Price Target to $20.00 - MarketBeat
Analyst Scoreboard: 4 Ratings For Evolus - Benzinga
Needham & Company LLC Reaffirms "Buy" Rating for Evolus (NASDAQ:EOLS) - MarketBeat
Mizuho shows confidence in Evolus execution post-Analyst Day, bumps stock PT - Investing.com
Evolus (NASDAQ:EOLS) Reaches New 1-Year High at $16.42 - MarketBeat
Evolus stock soars to 52-week high, hits $16.33 amid robust growth - Investing.com
Evolus Inc (EOLS) Shares Up 7.43% on Sep 12 - GuruFocus.com
Evolus, Inc. (NASDAQ:EOLS) CFO Sandra Beaver Sells 3,276 Shares - Defense World
Evolus (NASDAQ:EOLS) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
Evolus stock sees gains attention as Analyst Day approachesMizuho - Investing.com
Evolus' (EOLS) Overweight Rating Reiterated at Cantor Fitzgerald - MarketBeat
Evolus stock sees gains attention as Analyst Day approachesMizuho By Investing.com - Investing.com Canada
Evolus stock sees gains attention as Analyst Day approachesMizuho - Investing.com India
Evolus stock sees gains attention as Analyst Day approachesMizuho By Investing.com - Investing.com UK
Evolus, Inc. (NASDAQ:EOLS) CFO Sandra Beaver Sells 3,276 Shares - MarketBeat
Evolus (NASDAQ:EOLS) Shares Gap Down to $15.41 - Defense World
Evolus (NASDAQ:EOLS) Shares Gap Down to $15.41 - MarketBeat
Evolus CFO Sandra Beaver sells shares worth over $49,000 - Investing.com India
Evolus CFO Sandra Beaver sells shares worth over $49,000 - Investing.com
Evolus CFO Sandra Beaver sells shares worth over $49,000 By Investing.com - Investing.com UK
Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024 - Business Wire
Evolus executive sells over $89k in company stock By Investing.com - Investing.com Australia
Evolus, Inc. (NASDAQ:EOLS) CMO Tomoko Yamagishi-Dressler Sells 5,631 Shares - MarketBeat
Evolus executive sells over $89k in company stock - Investing.com
Evolus executive sells over $89k in company stock By Investing.com - Investing.com Canada
Evolus executive sells over $89k in company stock By Investing.com - Investing.com UK
'Barbie Botox' goes viral but doctors inject caution - Yahoo News Canada
(EOLS) Proactive Strategies - Stock Traders Daily
Evolus Posts First-Ever Profit Thanks To Jeuveau's Popularity - Finimize
How To Buy Evolus Inc Stock Online in August 2024 - Traders Union
Evolus, Inc. (NASDAQ:EOLS): Is Breakeven Near? - Simply Wall St
Evolus stock soars to 52-week high, hits $15.44 By Investing.com - Investing.com Australia
Mizuho sees strong upside for Evolus stock with 2025 milestones ahead - Investing.com India
Evolus Inc Stock (EOLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):